

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.26724349 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.05644361 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.80191456 |
| 4 | ATP synthesis coupled proton transport (GO:0015986) | 4.80191456 |
| 5 | barbed-end actin filament capping (GO:0051016) | 4.68822229 |
| 6 | protein retention in ER lumen (GO:0006621) | 4.55384978 |
| 7 | respiratory electron transport chain (GO:0022904) | 4.45559856 |
| 8 | electron transport chain (GO:0022900) | 4.36286477 |
| 9 | protein localization to endosome (GO:0036010) | 4.25504418 |
| 10 | glycosphingolipid catabolic process (GO:0046479) | 4.20796511 |
| 11 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.16306902 |
| 12 | sensory perception of smell (GO:0007608) | 4.10411255 |
| 13 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.99641487 |
| 14 | regulation of early endosome to late endosome transport (GO:2000641) | 3.89804508 |
| 15 | neuronal action potential propagation (GO:0019227) | 3.77985138 |
| 16 | glycolipid catabolic process (GO:0019377) | 3.75720141 |
| 17 | neuron cell-cell adhesion (GO:0007158) | 3.73529795 |
| 18 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.69582751 |
| 19 | fatty acid elongation (GO:0030497) | 3.66123839 |
| 20 | central nervous system myelination (GO:0022010) | 3.64170060 |
| 21 | axon ensheathment in central nervous system (GO:0032291) | 3.64170060 |
| 22 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.58155034 |
| 23 | cell-cell junction maintenance (GO:0045217) | 3.54737748 |
| 24 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.53656930 |
| 25 | semaphorin-plexin signaling pathway (GO:0071526) | 3.51277020 |
| 26 | synaptic vesicle exocytosis (GO:0016079) | 3.49953403 |
| 27 | Golgi transport vesicle coating (GO:0048200) | 3.45943951 |
| 28 | COPI coating of Golgi vesicle (GO:0048205) | 3.45943951 |
| 29 | glucose 6-phosphate metabolic process (GO:0051156) | 3.43416350 |
| 30 | proline biosynthetic process (GO:0006561) | 3.41223416 |
| 31 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.40294679 |
| 32 | detection of calcium ion (GO:0005513) | 3.28980920 |
| 33 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.27253280 |
| 34 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.27148882 |
| 35 | adhesion of symbiont to host (GO:0044406) | 3.21076417 |
| 36 | regulation of cell communication by electrical coupling (GO:0010649) | 3.20803951 |
| 37 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.19051292 |
| 38 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.14567690 |
| 39 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.14567690 |
| 40 | virion attachment to host cell (GO:0019062) | 3.13556591 |
| 41 | adhesion of symbiont to host cell (GO:0044650) | 3.13556591 |
| 42 | activation of Rac GTPase activity (GO:0032863) | 3.13037728 |
| 43 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.11333050 |
| 44 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.08210141 |
| 45 | vocalization behavior (GO:0071625) | 3.07908405 |
| 46 | sodium ion export (GO:0071436) | 3.06544809 |
| 47 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.04141160 |
| 48 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.02740791 |
| 49 | regulation of cholesterol homeostasis (GO:2000188) | 3.02435805 |
| 50 | ceramide catabolic process (GO:0046514) | 3.01947094 |
| 51 | angiotensin maturation (GO:0002003) | 3.01148313 |
| 52 | hydrogen ion transmembrane transport (GO:1902600) | 2.98410065 |
| 53 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.97701173 |
| 54 | epithelial cell-cell adhesion (GO:0090136) | 2.97257344 |
| 55 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.96441832 |
| 56 | substantia nigra development (GO:0021762) | 2.94027005 |
| 57 | stress fiber assembly (GO:0043149) | 2.92964088 |
| 58 | glutamate secretion (GO:0014047) | 2.92809502 |
| 59 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.92476669 |
| 60 | presynaptic membrane assembly (GO:0097105) | 2.92287619 |
| 61 | activation of MAPKKK activity (GO:0000185) | 2.88252379 |
| 62 | amino sugar catabolic process (GO:0046348) | 2.87509204 |
| 63 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.84774530 |
| 64 | regulation of extracellular matrix disassembly (GO:0010715) | 2.84242943 |
| 65 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.83923788 |
| 66 | modulation by symbiont of host cellular process (GO:0044068) | 2.83372932 |
| 67 | regulation of cholesterol storage (GO:0010885) | 2.83053256 |
| 68 | response to acidic pH (GO:0010447) | 2.82820470 |
| 69 | sphingolipid catabolic process (GO:0030149) | 2.82619039 |
| 70 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.82412617 |
| 71 | dopamine receptor signaling pathway (GO:0007212) | 2.82028518 |
| 72 | signal complex assembly (GO:0007172) | 2.82009815 |
| 73 | behavioral response to cocaine (GO:0048148) | 2.80171495 |
| 74 | ATP biosynthetic process (GO:0006754) | 2.79667852 |
| 75 | presynaptic membrane organization (GO:0097090) | 2.79257887 |
| 76 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.77342041 |
| 77 | layer formation in cerebral cortex (GO:0021819) | 2.76177281 |
| 78 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.73429109 |
| 79 | protein localization to synapse (GO:0035418) | 2.73336396 |
| 80 | negative regulation of cell size (GO:0045792) | 2.72776884 |
| 81 | protein localization to cilium (GO:0061512) | 2.72381788 |
| 82 | mannose metabolic process (GO:0006013) | 2.71527415 |
| 83 | modulation by virus of host process (GO:0019054) | 2.70197731 |
| 84 | proton transport (GO:0015992) | 2.69857967 |
| 85 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.69433823 |
| 86 | positive regulation of synapse maturation (GO:0090129) | 2.69158849 |
| 87 | transmission of nerve impulse (GO:0019226) | 2.68514505 |
| 88 | adenosine receptor signaling pathway (GO:0001973) | 2.68440008 |
| 89 | membrane lipid catabolic process (GO:0046466) | 2.68391601 |
| 90 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.68025869 |
| 91 | cellular response to epinephrine stimulus (GO:0071872) | 2.67252703 |
| 92 | neuron recognition (GO:0008038) | 2.66842546 |
| 93 | hydrogen transport (GO:0006818) | 2.66554011 |
| 94 | apoptotic process involved in morphogenesis (GO:0060561) | 2.64647046 |
| 95 | creatine metabolic process (GO:0006600) | 2.63606357 |
| 96 | pinocytosis (GO:0006907) | 2.63575147 |
| 97 | regulation of superoxide anion generation (GO:0032928) | 2.62806035 |
| 98 | response to epinephrine (GO:0071871) | 2.62617150 |
| 99 | pentose-phosphate shunt (GO:0006098) | 2.62357885 |
| 100 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.61890993 |
| 101 | transferrin transport (GO:0033572) | 2.61638355 |
| 102 | regulation of defense response to virus by virus (GO:0050690) | 2.61506702 |
| 103 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.61402311 |
| 104 | cellular response to prostaglandin stimulus (GO:0071379) | 2.60386016 |
| 105 | modulation by virus of host morphology or physiology (GO:0019048) | 2.59507171 |
| 106 | chaperone-mediated protein transport (GO:0072321) | 2.59321650 |
| 107 | amyloid precursor protein catabolic process (GO:0042987) | 2.58457669 |
| 108 | glucose catabolic process (GO:0006007) | 2.58278742 |
| 109 | regulation of synaptic vesicle transport (GO:1902803) | 2.58129258 |
| 110 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.57889643 |
| 111 | regulation of ARF protein signal transduction (GO:0032012) | 2.57857598 |
| 112 | regulation of podosome assembly (GO:0071801) | 2.57735729 |
| 113 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.56848132 |
| 114 | endothelial cell chemotaxis (GO:0035767) | 2.56557877 |
| 115 | protein maturation by protein folding (GO:0022417) | 2.56514526 |
| 116 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.55700179 |
| 117 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.55546020 |
| 118 | negative regulation of neurotransmitter transport (GO:0051589) | 2.54942173 |
| 119 | positive regulation of pseudopodium assembly (GO:0031274) | 2.54857459 |
| 120 | regulation of synapse structural plasticity (GO:0051823) | 2.54699587 |
| 121 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.53869714 |
| 122 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.53722289 |
| 123 | proline metabolic process (GO:0006560) | 2.53092966 |
| 124 | UV protection (GO:0009650) | 2.53029760 |
| 125 | positive regulation of receptor recycling (GO:0001921) | 2.52898064 |
| 126 | regulation of protein kinase A signaling (GO:0010738) | 2.52011324 |
| 127 | neuromuscular process controlling posture (GO:0050884) | 2.51800826 |
| 128 | sensory perception of chemical stimulus (GO:0007606) | 2.50067437 |
| 129 | oligosaccharide catabolic process (GO:0009313) | 2.48343188 |
| 130 | adherens junction assembly (GO:0034333) | 2.47452836 |
| 131 | trivalent inorganic cation transport (GO:0072512) | 2.47426220 |
| 132 | ferric iron transport (GO:0015682) | 2.47426220 |
| 133 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.47008222 |
| 134 | neurotransmitter secretion (GO:0007269) | 2.46033342 |
| 135 | cell junction maintenance (GO:0034331) | 2.45924137 |
| 136 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.45373572 |
| 137 | negative regulation of protein localization to cell surface (GO:2000009) | 2.44412823 |
| 138 | glutathione biosynthetic process (GO:0006750) | 2.43803593 |
| 139 | N-acetylneuraminate metabolic process (GO:0006054) | 2.43071387 |
| 140 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.42965481 |
| 141 | NIK/NF-kappaB signaling (GO:0038061) | 2.41885428 |
| 142 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.41490903 |
| 143 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.41473212 |
| 144 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.41376641 |
| 145 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.41020605 |
| 146 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.40967125 |
| 147 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.40930647 |
| 148 | protein neddylation (GO:0045116) | 2.40507849 |
| 149 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.40065545 |
| 150 | actin filament bundle assembly (GO:0051017) | 2.39665847 |
| 151 | actin filament bundle organization (GO:0061572) | 2.39665847 |
| 152 | basement membrane organization (GO:0071711) | 2.39583836 |
| 153 | regulation of extracellular matrix organization (GO:1903053) | 2.39543021 |
| 154 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.39436242 |
| 155 | axonal fasciculation (GO:0007413) | 2.38920959 |
| 156 | mating behavior (GO:0007617) | 2.38831753 |
| 157 | myelination (GO:0042552) | 2.38295375 |
| 158 | neurotransmitter catabolic process (GO:0042135) | 2.37850960 |
| 159 | regulation of glutamate secretion (GO:0014048) | 2.37635346 |
| 160 | regulation of cholesterol metabolic process (GO:0090181) | 2.37610400 |
| 161 | female mating behavior (GO:0060180) | 2.37084767 |
| 162 | cell volume homeostasis (GO:0006884) | 2.36822224 |
| 163 | activation of protein kinase A activity (GO:0034199) | 2.36587317 |
| 164 | neuron-neuron synaptic transmission (GO:0007270) | 2.36189612 |
| 165 | tricarboxylic acid cycle (GO:0006099) | 2.35842277 |
| 166 | bone resorption (GO:0045453) | 2.35595374 |
| 167 | regulation of vesicle fusion (GO:0031338) | 2.35519598 |
| 168 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.35419307 |
| 169 | neurotransmitter transport (GO:0006836) | 2.35414943 |
| 170 | regulation of protein dephosphorylation (GO:0035304) | 2.35289896 |
| 171 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.34777177 |
| 172 | adult walking behavior (GO:0007628) | 2.34152922 |
| 173 | axon ensheathment (GO:0008366) | 2.34010015 |
| 174 | ensheathment of neurons (GO:0007272) | 2.34010015 |
| 175 | receptor catabolic process (GO:0032801) | 2.33338850 |
| 176 | apoptotic cell clearance (GO:0043277) | 2.32116945 |
| 177 | glutamate receptor signaling pathway (GO:0007215) | 2.32061853 |
| 178 | synaptic vesicle maturation (GO:0016188) | 2.31413293 |
| 179 | amino acid import (GO:0043090) | 2.31317910 |
| 180 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.31147174 |
| 181 | regulation of collateral sprouting (GO:0048670) | 2.31065388 |
| 182 | receptor recycling (GO:0001881) | 2.31058559 |
| 183 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.30425601 |
| 184 | neurotransmitter uptake (GO:0001504) | 2.30307736 |
| 185 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.29160056 |
| 186 | NADH metabolic process (GO:0006734) | 2.28896901 |
| 187 | membrane hyperpolarization (GO:0060081) | 2.28870472 |
| 188 | inner mitochondrial membrane organization (GO:0007007) | 2.28107055 |
| 189 | multicellular organismal signaling (GO:0035637) | 2.27566328 |
| 190 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.27555437 |
| 191 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.27128029 |
| 192 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.25481340 |
| 193 | neuronal action potential (GO:0019228) | 2.24598158 |
| 194 | cerebellar granule cell differentiation (GO:0021707) | 2.24022838 |
| 195 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.23808868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.09708641 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.66944925 |
| 3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.17979164 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.14812960 |
| 5 | LXR_22292898_ChIP-Seq_THP-1_Human | 3.12837373 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.96449653 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.89091076 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.71006519 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.67130962 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.56005455 |
| 11 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.50991542 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.42323044 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.40746635 |
| 14 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.32585668 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.31957619 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.31957619 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.31328539 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.27173268 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.27039266 |
| 20 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.26895226 |
| 21 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.25495649 |
| 22 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.25401653 |
| 23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.24966297 |
| 24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.23532609 |
| 25 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.22502655 |
| 26 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.22236348 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.22080543 |
| 28 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.17543280 |
| 29 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.10514859 |
| 30 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.05623409 |
| 31 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.02067509 |
| 32 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.99662926 |
| 33 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.98910211 |
| 34 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.98752440 |
| 35 | KDM2B_26808549_Chip-Seq_K562_Human | 1.97506777 |
| 36 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.96207472 |
| 37 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.92328407 |
| 38 | MYC_22102868_ChIP-Seq_BL_Human | 1.90016930 |
| 39 | VDR_22108803_ChIP-Seq_LS180_Human | 1.89759442 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.89183273 |
| 41 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.88523643 |
| 42 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.86936504 |
| 43 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.79990901 |
| 44 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.79725286 |
| 45 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75782121 |
| 46 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.74715069 |
| 47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.74010504 |
| 48 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.72358751 |
| 49 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.71761573 |
| 50 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.70276766 |
| 51 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.69579201 |
| 52 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.68806592 |
| 53 | P68_20966046_ChIP-Seq_HELA_Human | 1.68552056 |
| 54 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.67777410 |
| 55 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.66257056 |
| 56 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.65459631 |
| 57 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.64536873 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.63298983 |
| 59 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.61978798 |
| 60 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.59581434 |
| 61 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.58156602 |
| 62 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.58085498 |
| 63 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.56394437 |
| 64 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.56383815 |
| 65 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.55128663 |
| 66 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.52519082 |
| 67 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.52000374 |
| 68 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.48704525 |
| 69 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.48618392 |
| 70 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.44911812 |
| 71 | P300_19829295_ChIP-Seq_ESCs_Human | 1.44199582 |
| 72 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.40344644 |
| 73 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.38869769 |
| 74 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.37052069 |
| 75 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36509056 |
| 76 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.35740518 |
| 77 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.34838447 |
| 78 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.34658104 |
| 79 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34086391 |
| 80 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.33755589 |
| 81 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.32057770 |
| 82 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.31602580 |
| 83 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.31097347 |
| 84 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.30935630 |
| 85 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.29924575 |
| 86 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29425411 |
| 87 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29193524 |
| 88 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.29157300 |
| 89 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.29018463 |
| 90 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.28368461 |
| 91 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28136206 |
| 92 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.28087177 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.27213938 |
| 94 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.26844127 |
| 95 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.24986898 |
| 96 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.24546477 |
| 97 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.23929379 |
| 98 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22726613 |
| 99 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.21603735 |
| 100 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.19650332 |
| 101 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.19508793 |
| 102 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.17767544 |
| 103 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.17218747 |
| 104 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.16861812 |
| 105 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.16382975 |
| 106 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.16044000 |
| 107 | SA1_27219007_Chip-Seq_Bcells_Human | 1.14092720 |
| 108 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.13961130 |
| 109 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.12811088 |
| 110 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.12533711 |
| 111 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.11850101 |
| 112 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11642893 |
| 113 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.11309558 |
| 114 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10852922 |
| 115 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10669312 |
| 116 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.09778829 |
| 117 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09628887 |
| 118 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.09417350 |
| 119 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08803324 |
| 120 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.08445725 |
| 121 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.06972932 |
| 122 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.06219823 |
| 123 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06017093 |
| 124 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05962743 |
| 125 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.05750372 |
| 126 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.05521601 |
| 127 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.05201216 |
| 128 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05184760 |
| 129 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.04828805 |
| 130 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03668779 |
| 131 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03369322 |
| 132 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03351927 |
| 133 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03254823 |
| 134 | FUS_26573619_Chip-Seq_HEK293_Human | 1.02369429 |
| 135 | MAF_26560356_Chip-Seq_TH1_Human | 1.01989684 |
| 136 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01559709 |
| 137 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.00958213 |
| 138 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.00848145 |
| 139 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.00827982 |
| 140 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.00753040 |
| 141 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.00642537 |
| 142 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.00574021 |
| 143 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.00187322 |
| 144 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.99962668 |
| 145 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.99349369 |
| 146 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99294067 |
| 147 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.99223254 |
| 148 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.98546965 |
| 149 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.98366797 |
| 150 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97911628 |
| 151 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97908938 |
| 152 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.97793734 |
| 153 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97679212 |
| 154 | MAF_26560356_Chip-Seq_TH2_Human | 0.97667328 |
| 155 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.97520582 |
| 156 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97242532 |
| 157 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95904809 |
| 158 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.95786725 |
| 159 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.95669485 |
| 160 | AR_25329375_ChIP-Seq_VCAP_Human | 0.95489888 |
| 161 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.93076580 |
| 162 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91121054 |
| 163 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.90910725 |
| 164 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90642658 |
| 165 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.90332016 |
| 166 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.90137215 |
| 167 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89981038 |
| 168 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87765322 |
| 169 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.87127330 |
| 170 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.87127330 |
| 171 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.87021727 |
| 172 | STAT3_23295773_ChIP-Seq_U87_Human | 0.85710435 |
| 173 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.85601363 |
| 174 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85162931 |
| 175 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85162931 |
| 176 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.84546152 |
| 177 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.83705924 |
| 178 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.83382752 |
| 179 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.83013739 |
| 180 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.81975484 |
| 181 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.81540165 |
| 182 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.81465445 |
| 183 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.79860330 |
| 184 | TCF4_23295773_ChIP-Seq_U87_Human | 0.78819030 |
| 185 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.77820034 |
| 186 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.77299354 |
| 187 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.77137025 |
| 188 | JUN_21703547_ChIP-Seq_K562_Human | 0.76897645 |
| 189 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.76794921 |
| 190 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76794921 |
| 191 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.76763010 |
| 192 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.76551068 |
| 193 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.76459130 |
| 194 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.75846062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.87028428 |
| 2 | MP0003880_abnormal_central_pattern | 4.31117881 |
| 3 | MP0001984_abnormal_olfaction | 3.95908779 |
| 4 | MP0009840_abnormal_foam_cell | 3.56096816 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 3.29136321 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 3.22062051 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 3.10962620 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 3.08543286 |
| 9 | MP0005257_abnormal_intraocular_pressure | 2.90715594 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.90465554 |
| 11 | MP0004270_analgesia | 2.85700686 |
| 12 | MP0001849_ear_inflammation | 2.73899265 |
| 13 | MP0003635_abnormal_synaptic_transmissio | 2.65967361 |
| 14 | MP0009046_muscle_twitch | 2.64959601 |
| 15 | MP0002064_seizures | 2.54215513 |
| 16 | MP0003303_peritoneal_inflammation | 2.45846277 |
| 17 | MP0002272_abnormal_nervous_system | 2.43445387 |
| 18 | MP0003183_abnormal_peptide_metabolism | 2.41009529 |
| 19 | MP0003123_paternal_imprinting | 2.39493090 |
| 20 | MP0009745_abnormal_behavioral_response | 2.38756556 |
| 21 | MP0000751_myopathy | 2.31840555 |
| 22 | MP0001529_abnormal_vocalization | 2.25550359 |
| 23 | MP0008260_abnormal_autophagy | 2.15708273 |
| 24 | MP0005360_urolithiasis | 2.13574233 |
| 25 | MP0002063_abnormal_learning/memory/cond | 2.12925763 |
| 26 | MP0002734_abnormal_mechanical_nocicepti | 2.11338201 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 2.07805836 |
| 28 | MP0002139_abnormal_hepatobiliary_system | 2.07654519 |
| 29 | MP0002822_catalepsy | 2.06398929 |
| 30 | MP0001486_abnormal_startle_reflex | 2.04392729 |
| 31 | MP0002572_abnormal_emotion/affect_behav | 2.01292292 |
| 32 | MP0004145_abnormal_muscle_electrophysio | 2.01103248 |
| 33 | MP0003075_altered_response_to | 1.99530442 |
| 34 | MP0001968_abnormal_touch/_nociception | 1.96457919 |
| 35 | MP0006276_abnormal_autonomic_nervous | 1.93101327 |
| 36 | MP0009278_abnormal_bone_marrow | 1.89229443 |
| 37 | MP0001440_abnormal_grooming_behavior | 1.89195111 |
| 38 | MP0001501_abnormal_sleep_pattern | 1.83050801 |
| 39 | MP0004510_myositis | 1.81256012 |
| 40 | MP0003329_amyloid_beta_deposits | 1.80088447 |
| 41 | MP0003453_abnormal_keratinocyte_physiol | 1.76491793 |
| 42 | MP0003646_muscle_fatigue | 1.74697616 |
| 43 | MP0001905_abnormal_dopamine_level | 1.70292693 |
| 44 | MP0002876_abnormal_thyroid_physiology | 1.67367001 |
| 45 | MP0004142_abnormal_muscle_tone | 1.66766304 |
| 46 | MP0000678_abnormal_parathyroid_gland | 1.66714554 |
| 47 | MP0002736_abnormal_nociception_after | 1.65726311 |
| 48 | MP0002067_abnormal_sensory_capabilities | 1.65434422 |
| 49 | MP0000920_abnormal_myelination | 1.63581053 |
| 50 | MP0003436_decreased_susceptibility_to | 1.63263494 |
| 51 | MP0002184_abnormal_innervation | 1.62857486 |
| 52 | MP0002735_abnormal_chemical_nociception | 1.61679416 |
| 53 | MP0004036_abnormal_muscle_relaxation | 1.59483618 |
| 54 | MP0002089_abnormal_postnatal_growth/wei | 1.56445012 |
| 55 | MP0000537_abnormal_urethra_morphology | 1.54925116 |
| 56 | MP0001970_abnormal_pain_threshold | 1.52635079 |
| 57 | MP0004215_abnormal_myocardial_fiber | 1.52584469 |
| 58 | MP0004924_abnormal_behavior | 1.51057115 |
| 59 | MP0005386_behavior/neurological_phenoty | 1.51057115 |
| 60 | MP0002653_abnormal_ependyma_morphology | 1.50517374 |
| 61 | MP0009379_abnormal_foot_pigmentation | 1.50064788 |
| 62 | MP0000566_synostosis | 1.47238971 |
| 63 | MP0002733_abnormal_thermal_nociception | 1.46502039 |
| 64 | MP0005423_abnormal_somatic_nervous | 1.43380359 |
| 65 | MP0000858_altered_metastatic_potential | 1.43009883 |
| 66 | MP0003566_abnormal_cell_adhesion | 1.41785732 |
| 67 | MP0000749_muscle_degeneration | 1.40210179 |
| 68 | MP0005645_abnormal_hypothalamus_physiol | 1.40174059 |
| 69 | MP0000778_abnormal_nervous_system | 1.38078931 |
| 70 | MP0000490_abnormal_crypts_of | 1.35518308 |
| 71 | MP0004264_abnormal_extraembryonic_tissu | 1.35489603 |
| 72 | MP0003300_gastrointestinal_ulcer | 1.34579557 |
| 73 | MP0003879_abnormal_hair_cell | 1.33004625 |
| 74 | MP0002909_abnormal_adrenal_gland | 1.29616280 |
| 75 | MP0002557_abnormal_social/conspecific_i | 1.27333258 |
| 76 | MP0002229_neurodegeneration | 1.26674135 |
| 77 | MP0000747_muscle_weakness | 1.26009957 |
| 78 | MP0004742_abnormal_vestibular_system | 1.25686251 |
| 79 | MP0002998_abnormal_bone_remodeling | 1.25378908 |
| 80 | MP0003690_abnormal_glial_cell | 1.23899108 |
| 81 | MP0002066_abnormal_motor_capabilities/c | 1.22518284 |
| 82 | MP0008569_lethality_at_weaning | 1.22072367 |
| 83 | MP0002249_abnormal_larynx_morphology | 1.20624311 |
| 84 | MP0005076_abnormal_cell_differentiation | 1.20339629 |
| 85 | MP0002882_abnormal_neuron_morphology | 1.19836375 |
| 86 | MP0010030_abnormal_orbit_morphology | 1.18128713 |
| 87 | MP0004185_abnormal_adipocyte_glucose | 1.18087857 |
| 88 | MP0002796_impaired_skin_barrier | 1.17164585 |
| 89 | MP0010386_abnormal_urinary_bladder | 1.16687379 |
| 90 | MP0000343_altered_response_to | 1.16482720 |
| 91 | MP0006036_abnormal_mitochondrial_physio | 1.15868252 |
| 92 | MP0010155_abnormal_intestine_physiology | 1.15523094 |
| 93 | MP0004947_skin_inflammation | 1.14346102 |
| 94 | MP0005365_abnormal_bile_salt | 1.14231601 |
| 95 | MP0005166_decreased_susceptibility_to | 1.13890576 |
| 96 | MP0000013_abnormal_adipose_tissue | 1.13796213 |
| 97 | MP0004381_abnormal_hair_follicle | 1.12074589 |
| 98 | MP0004043_abnormal_pH_regulation | 1.12042111 |
| 99 | MP0003634_abnormal_glial_cell | 1.11599658 |
| 100 | MP0005551_abnormal_eye_electrophysiolog | 1.11084010 |
| 101 | MP0001485_abnormal_pinna_reflex | 1.10156279 |
| 102 | MP0005501_abnormal_skin_physiology | 1.10082297 |
| 103 | MP0005646_abnormal_pituitary_gland | 1.07685490 |
| 104 | MP0005620_abnormal_muscle_contractility | 1.07350219 |
| 105 | MP0005464_abnormal_platelet_physiology | 1.07232745 |
| 106 | MP0005409_darkened_coat_color | 1.06366028 |
| 107 | MP0004484_altered_response_of | 1.05158692 |
| 108 | MP0003091_abnormal_cell_migration | 1.04135261 |
| 109 | MP0005535_abnormal_body_temperature | 1.03739403 |
| 110 | MP0003137_abnormal_impulse_conducting | 1.03699307 |
| 111 | MP0003195_calcinosis | 1.03668058 |
| 112 | MP0000955_abnormal_spinal_cord | 1.03043175 |
| 113 | MP0008874_decreased_physiological_sensi | 1.02726324 |
| 114 | MP0006035_abnormal_mitochondrial_morpho | 0.98673102 |
| 115 | MP0001533_abnormal_skeleton_physiology | 0.98487464 |
| 116 | MP0004130_abnormal_muscle_cell | 0.98110006 |
| 117 | MP0004019_abnormal_vitamin_homeostasis | 0.97162735 |
| 118 | MP0009333_abnormal_splenocyte_physiolog | 0.96232646 |
| 119 | MP0004085_abnormal_heartbeat | 0.96172123 |
| 120 | MP0005330_cardiomyopathy | 0.94690498 |
| 121 | MP0003633_abnormal_nervous_system | 0.94511138 |
| 122 | MP0001963_abnormal_hearing_physiology | 0.91906529 |
| 123 | MP0002877_abnormal_melanocyte_morpholog | 0.91875025 |
| 124 | MP0002752_abnormal_somatic_nervous | 0.91185786 |
| 125 | MP0001502_abnormal_circadian_rhythm | 0.90245239 |
| 126 | MP0003631_nervous_system_phenotype | 0.88171883 |
| 127 | MP0004084_abnormal_cardiac_muscle | 0.87700751 |
| 128 | MP0004885_abnormal_endolymph | 0.87311706 |
| 129 | MP0004811_abnormal_neuron_physiology | 0.86891475 |
| 130 | MP0006082_CNS_inflammation | 0.86662879 |
| 131 | MP0005451_abnormal_body_composition | 0.86157204 |
| 132 | MP0002896_abnormal_bone_mineralization | 0.86025731 |
| 133 | MP0002106_abnormal_muscle_physiology | 0.85459175 |
| 134 | MP0005666_abnormal_adipose_tissue | 0.84857227 |
| 135 | MP0002090_abnormal_vision | 0.84345027 |
| 136 | MP0002332_abnormal_exercise_endurance | 0.84089466 |
| 137 | MP0001663_abnormal_digestive_system | 0.83685511 |
| 138 | MP0009780_abnormal_chondrocyte_physiolo | 0.82716938 |
| 139 | MP0003279_aneurysm | 0.82470933 |
| 140 | MP0005369_muscle_phenotype | 0.80279807 |
| 141 | MP0003878_abnormal_ear_physiology | 0.79728988 |
| 142 | MP0005377_hearing/vestibular/ear_phenot | 0.79728988 |
| 143 | MP0000477_abnormal_intestine_morphology | 0.79116049 |
| 144 | MP0000604_amyloidosis | 0.78979985 |
| 145 | MP0004233_abnormal_muscle_weight | 0.78979430 |
| 146 | MP0005167_abnormal_blood-brain_barrier | 0.78464343 |
| 147 | MP0002972_abnormal_cardiac_muscle | 0.78160744 |
| 148 | MP0001664_abnormal_digestion | 0.77506575 |
| 149 | MP0005381_digestive/alimentary_phenotyp | 0.77299960 |
| 150 | MP0001188_hyperpigmentation | 0.77216731 |
| 151 | MP0002098_abnormal_vibrissa_morphology | 0.76266261 |
| 152 | MP0008875_abnormal_xenobiotic_pharmacok | 0.75527527 |
| 153 | MP0003866_abnormal_defecation | 0.74870855 |
| 154 | MP0005025_abnormal_response_to | 0.74662359 |
| 155 | MP0002069_abnormal_eating/drinking_beha | 0.73750836 |
| 156 | MP0005499_abnormal_olfactory_system | 0.72645380 |
| 157 | MP0005394_taste/olfaction_phenotype | 0.72645380 |
| 158 | MP0003632_abnormal_nervous_system | 0.72603912 |
| 159 | MP0001727_abnormal_embryo_implantation | 0.72168538 |
| 160 | MP0005390_skeleton_phenotype | 0.71860160 |
| 161 | MP0004858_abnormal_nervous_system | 0.71542113 |
| 162 | MP0000681_abnormal_thyroid_gland | 0.71412411 |
| 163 | MP0005375_adipose_tissue_phenotype | 0.70111188 |
| 164 | MP0000759_abnormal_skeletal_muscle | 0.70089912 |
| 165 | MP0003806_abnormal_nucleotide_metabolis | 0.69940434 |
| 166 | MP0002152_abnormal_brain_morphology | 0.68433461 |
| 167 | MP0005310_abnormal_salivary_gland | 0.67426385 |
| 168 | MP0002419_abnormal_innate_immunity | 0.65920689 |
| 169 | MP0005023_abnormal_wound_healing | 0.63617399 |
| 170 | MP0002148_abnormal_hypersensitivity_rea | 0.63087409 |
| 171 | MP0000015_abnormal_ear_pigmentation | 0.62991700 |
| 172 | MP0003448_altered_tumor_morphology | 0.62925605 |
| 173 | MP0005165_increased_susceptibility_to | 0.59921865 |
| 174 | MP0001666_abnormal_nutrient_absorption | 0.59615590 |
| 175 | MP0004272_abnormal_basement_membrane | 0.59159129 |
| 176 | MP0000003_abnormal_adipose_tissue | 0.55678862 |
| 177 | MP0005508_abnormal_skeleton_morphology | 0.53955567 |
| 178 | MP0002254_reproductive_system_inflammat | 0.53799989 |
| 179 | MP0001216_abnormal_epidermal_layer | 0.51405324 |
| 180 | MP0010368_abnormal_lymphatic_system | 0.51144373 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.90951675 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.58031048 |
| 3 | Focal motor seizures (HP:0011153) | 4.43919192 |
| 4 | Acute encephalopathy (HP:0006846) | 4.25798111 |
| 5 | Progressive macrocephaly (HP:0004481) | 4.17961637 |
| 6 | Mitochondrial inheritance (HP:0001427) | 4.05142679 |
| 7 | Myokymia (HP:0002411) | 4.03861674 |
| 8 | Dysostosis multiplex (HP:0000943) | 3.80316901 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 3.79144993 |
| 10 | Atonic seizures (HP:0010819) | 3.78746553 |
| 11 | Hepatocellular necrosis (HP:0001404) | 3.53536064 |
| 12 | Distal upper limb amyotrophy (HP:0007149) | 3.46797050 |
| 13 | Upper limb amyotrophy (HP:0009129) | 3.46797050 |
| 14 | Increased CSF lactate (HP:0002490) | 3.41830343 |
| 15 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.35957873 |
| 16 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.26009983 |
| 17 | Axonal loss (HP:0003447) | 3.17882126 |
| 18 | Exercise-induced myalgia (HP:0003738) | 3.15961974 |
| 19 | Hepatic necrosis (HP:0002605) | 3.15776734 |
| 20 | Hyperacusis (HP:0010780) | 3.11789081 |
| 21 | Pheochromocytoma (HP:0002666) | 3.08256705 |
| 22 | Absence seizures (HP:0002121) | 3.06511803 |
| 23 | Cerebral edema (HP:0002181) | 3.05326262 |
| 24 | Calf muscle hypertrophy (HP:0008981) | 3.02668567 |
| 25 | Focal seizures (HP:0007359) | 3.01890322 |
| 26 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.01117759 |
| 27 | Systemic lupus erythematosus (HP:0002725) | 2.99601463 |
| 28 | Neuronal loss in central nervous system (HP:0002529) | 2.97536256 |
| 29 | Loss of speech (HP:0002371) | 2.96943896 |
| 30 | Hand muscle atrophy (HP:0009130) | 2.94600636 |
| 31 | Achilles tendon contracture (HP:0001771) | 2.92883449 |
| 32 | Retinal dysplasia (HP:0007973) | 2.88115896 |
| 33 | Sudden death (HP:0001699) | 2.84782363 |
| 34 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.83994528 |
| 35 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.83994528 |
| 36 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.83994528 |
| 37 | Dialeptic seizures (HP:0011146) | 2.81033162 |
| 38 | Mucopolysacchariduria (HP:0008155) | 2.78835983 |
| 39 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.78835983 |
| 40 | Neuroendocrine neoplasm (HP:0100634) | 2.77786438 |
| 41 | Apathy (HP:0000741) | 2.75513387 |
| 42 | Abnormality of glycolysis (HP:0004366) | 2.75352640 |
| 43 | Increased serum pyruvate (HP:0003542) | 2.75352640 |
| 44 | Vertebral compression fractures (HP:0002953) | 2.74477018 |
| 45 | J-shaped sella turcica (HP:0002680) | 2.73053819 |
| 46 | Visual hallucinations (HP:0002367) | 2.72654564 |
| 47 | Leukodystrophy (HP:0002415) | 2.69513956 |
| 48 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.68507800 |
| 49 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.68507800 |
| 50 | Diminished motivation (HP:0000745) | 2.67788526 |
| 51 | Obstructive sleep apnea (HP:0002870) | 2.65019767 |
| 52 | Neurofibrillary tangles (HP:0002185) | 2.64660656 |
| 53 | Optic disc pallor (HP:0000543) | 2.63106466 |
| 54 | Abnormality of the Achilles tendon (HP:0005109) | 2.62336204 |
| 55 | Epileptic encephalopathy (HP:0200134) | 2.61900738 |
| 56 | Insomnia (HP:0100785) | 2.59177930 |
| 57 | Nuclear cataract (HP:0100018) | 2.58843054 |
| 58 | Febrile seizures (HP:0002373) | 2.57607297 |
| 59 | Parakeratosis (HP:0001036) | 2.57305299 |
| 60 | Generalized tonic-clonic seizures (HP:0002069) | 2.56486972 |
| 61 | Respiratory failure (HP:0002878) | 2.55452842 |
| 62 | Distal lower limb amyotrophy (HP:0008944) | 2.53420587 |
| 63 | Thin bony cortex (HP:0002753) | 2.52362277 |
| 64 | Muscle fiber splitting (HP:0003555) | 2.51061287 |
| 65 | Renal Fanconi syndrome (HP:0001994) | 2.50729851 |
| 66 | Hyperventilation (HP:0002883) | 2.50022521 |
| 67 | Increased intramyocellular lipid droplets (HP:0012240) | 2.49126943 |
| 68 | Palpitations (HP:0001962) | 2.48911399 |
| 69 | Increased hepatocellular lipid droplets (HP:0006565) | 2.48664740 |
| 70 | Thoracic kyphosis (HP:0002942) | 2.48607452 |
| 71 | Lactic acidosis (HP:0003128) | 2.47257010 |
| 72 | Hyperparathyroidism (HP:0000843) | 2.45874879 |
| 73 | Vacuolated lymphocytes (HP:0001922) | 2.45841347 |
| 74 | Hemorrhage of the eye (HP:0011885) | 2.43390704 |
| 75 | Sensory axonal neuropathy (HP:0003390) | 2.41559268 |
| 76 | Lipid accumulation in hepatocytes (HP:0006561) | 2.39864727 |
| 77 | Exercise intolerance (HP:0003546) | 2.37639575 |
| 78 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.36711576 |
| 79 | Increased muscle lipid content (HP:0009058) | 2.32475866 |
| 80 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.32339592 |
| 81 | Purpura (HP:0000979) | 2.32284911 |
| 82 | Flat acetabular roof (HP:0003180) | 2.31031829 |
| 83 | Syncope (HP:0001279) | 2.29689205 |
| 84 | Cerebral inclusion bodies (HP:0100314) | 2.26211342 |
| 85 | Abnormality of the thoracic spine (HP:0100711) | 2.25893239 |
| 86 | Hyporeflexia of lower limbs (HP:0002600) | 2.21115018 |
| 87 | Cholecystitis (HP:0001082) | 2.19931541 |
| 88 | Abnormal gallbladder physiology (HP:0012438) | 2.19931541 |
| 89 | Termporal pattern (HP:0011008) | 2.17841169 |
| 90 | Insidious onset (HP:0003587) | 2.17841169 |
| 91 | Protrusio acetabuli (HP:0003179) | 2.16186198 |
| 92 | Mutism (HP:0002300) | 2.15827248 |
| 93 | Limb dystonia (HP:0002451) | 2.14883310 |
| 94 | Dementia (HP:0000726) | 2.14823629 |
| 95 | Growth hormone excess (HP:0000845) | 2.14373601 |
| 96 | Myotonia (HP:0002486) | 2.14019478 |
| 97 | Supranuclear gaze palsy (HP:0000605) | 2.13253385 |
| 98 | Anxiety (HP:0000739) | 2.12377519 |
| 99 | Abnormality of the calf musculature (HP:0001430) | 2.10914687 |
| 100 | Abnormality of the corticospinal tract (HP:0002492) | 2.10098698 |
| 101 | Lower limb amyotrophy (HP:0007210) | 2.09182168 |
| 102 | Muscle stiffness (HP:0003552) | 2.06390315 |
| 103 | Prolonged neonatal jaundice (HP:0006579) | 2.04250954 |
| 104 | Exercise-induced muscle cramps (HP:0003710) | 2.02805886 |
| 105 | Pathologic fracture (HP:0002756) | 2.02770599 |
| 106 | Progressive cerebellar ataxia (HP:0002073) | 2.02366373 |
| 107 | Ventricular fibrillation (HP:0001663) | 2.01120188 |
| 108 | Upper motor neuron abnormality (HP:0002127) | 1.99516070 |
| 109 | X-linked dominant inheritance (HP:0001423) | 1.99024015 |
| 110 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.98802422 |
| 111 | Annular pancreas (HP:0001734) | 1.97722529 |
| 112 | Dysmetria (HP:0001310) | 1.97503489 |
| 113 | Septate vagina (HP:0001153) | 1.96379046 |
| 114 | Gait imbalance (HP:0002141) | 1.96147078 |
| 115 | Cerebral aneurysm (HP:0004944) | 1.95624362 |
| 116 | Central scotoma (HP:0000603) | 1.92892838 |
| 117 | Distal lower limb muscle weakness (HP:0009053) | 1.92599170 |
| 118 | Vaginal atresia (HP:0000148) | 1.91423885 |
| 119 | Premature rupture of membranes (HP:0001788) | 1.90933802 |
| 120 | Cerebral hemorrhage (HP:0001342) | 1.90783913 |
| 121 | Prolonged QT interval (HP:0001657) | 1.90777132 |
| 122 | Medial flaring of the eyebrow (HP:0010747) | 1.89469184 |
| 123 | Bone pain (HP:0002653) | 1.89155145 |
| 124 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.88577524 |
| 125 | Long palpebral fissure (HP:0000637) | 1.88419317 |
| 126 | Myoglobinuria (HP:0002913) | 1.87954257 |
| 127 | Abnormality of the nasal mucosa (HP:0000433) | 1.86076964 |
| 128 | Xanthomatosis (HP:0000991) | 1.85024187 |
| 129 | Deep venous thrombosis (HP:0002625) | 1.84532194 |
| 130 | Genital tract atresia (HP:0001827) | 1.83098037 |
| 131 | Congenital primary aphakia (HP:0007707) | 1.83033319 |
| 132 | Turricephaly (HP:0000262) | 1.82794334 |
| 133 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.82741866 |
| 134 | Polygenic inheritance (HP:0010982) | 1.82368454 |
| 135 | Cervical subluxation (HP:0003308) | 1.82190940 |
| 136 | Peripheral hypomyelination (HP:0007182) | 1.82129076 |
| 137 | Paralysis (HP:0003470) | 1.80411880 |
| 138 | Ankle clonus (HP:0011448) | 1.80292176 |
| 139 | Abdominal distention (HP:0003270) | 1.80182781 |
| 140 | Flattened epiphyses (HP:0003071) | 1.80066388 |
| 141 | Broad-based gait (HP:0002136) | 1.79786760 |
| 142 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.78973457 |
| 143 | Short nail (HP:0001799) | 1.78560839 |
| 144 | Athetosis (HP:0002305) | 1.77219355 |
| 145 | Pointed chin (HP:0000307) | 1.76801609 |
| 146 | Action tremor (HP:0002345) | 1.76024188 |
| 147 | Ketoacidosis (HP:0001993) | 1.75215433 |
| 148 | Abnormal eating behavior (HP:0100738) | 1.74938152 |
| 149 | Muscle fiber inclusion bodies (HP:0100299) | 1.74723005 |
| 150 | Lethargy (HP:0001254) | 1.74659360 |
| 151 | Methylmalonic aciduria (HP:0012120) | 1.74058064 |
| 152 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.73845639 |
| 153 | Disinhibition (HP:0000734) | 1.73624967 |
| 154 | Multiple lipomas (HP:0001012) | 1.73173329 |
| 155 | Increased serum lactate (HP:0002151) | 1.73053539 |
| 156 | EMG: myopathic abnormalities (HP:0003458) | 1.73006601 |
| 157 | Methylmalonic acidemia (HP:0002912) | 1.72946836 |
| 158 | Intention tremor (HP:0002080) | 1.72571561 |
| 159 | Personality changes (HP:0000751) | 1.72062528 |
| 160 | CNS demyelination (HP:0007305) | 1.71439798 |
| 161 | Abnormality of renal resorption (HP:0011038) | 1.70925896 |
| 162 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.70551020 |
| 163 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.70551020 |
| 164 | Abnormality of glycolipid metabolism (HP:0010969) | 1.70551020 |
| 165 | Mitral regurgitation (HP:0001653) | 1.70090695 |
| 166 | Delusions (HP:0000746) | 1.70001469 |
| 167 | Paraparesis (HP:0002385) | 1.69177055 |
| 168 | Nephrogenic diabetes insipidus (HP:0009806) | 1.69050711 |
| 169 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.68800867 |
| 170 | Hypertensive crisis (HP:0100735) | 1.68790285 |
| 171 | Spastic gait (HP:0002064) | 1.68408219 |
| 172 | Emotional lability (HP:0000712) | 1.67157110 |
| 173 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.66817503 |
| 174 | Disproportionate tall stature (HP:0001519) | 1.66741522 |
| 175 | Rapidly progressive (HP:0003678) | 1.66686515 |
| 176 | Abnormality of macrophages (HP:0004311) | 1.64350859 |
| 177 | Hypercalcemia (HP:0003072) | 1.64016790 |
| 178 | Stridor (HP:0010307) | 1.63277793 |
| 179 | Broad distal phalanx of finger (HP:0009836) | 1.60855951 |
| 180 | Overriding aorta (HP:0002623) | 1.60766429 |
| 181 | Slow saccadic eye movements (HP:0000514) | 1.60094921 |
| 182 | Hypophosphatemia (HP:0002148) | 1.59407788 |
| 183 | Urinary incontinence (HP:0000020) | 1.57366187 |
| 184 | Elfin facies (HP:0004428) | 1.56780150 |
| 185 | Bronchomalacia (HP:0002780) | 1.56779205 |
| 186 | Broad face (HP:0000283) | 1.56627146 |
| 187 | Distal sensory impairment (HP:0002936) | 1.55885517 |
| 188 | Neonatal death (HP:0003811) | 1.55776524 |
| 189 | Lower limb asymmetry (HP:0100559) | 1.55069561 |
| 190 | Gastrointestinal dysmotility (HP:0002579) | 1.54676389 |
| 191 | Joint stiffness (HP:0001387) | 1.53697465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.33091891 |
| 2 | CASK | 3.27215995 |
| 3 | STK39 | 3.18922932 |
| 4 | SIK1 | 2.89104121 |
| 5 | IRAK3 | 2.88108914 |
| 6 | ERN1 | 2.78771569 |
| 7 | MAP3K11 | 2.64335219 |
| 8 | OXSR1 | 2.62614906 |
| 9 | ARAF | 2.55511274 |
| 10 | PHKG2 | 2.48343656 |
| 11 | PHKG1 | 2.48343656 |
| 12 | TESK1 | 2.47501134 |
| 13 | RIPK1 | 2.46051527 |
| 14 | EPHA4 | 2.39134038 |
| 15 | NTRK3 | 2.35817535 |
| 16 | SMG1 | 2.33201902 |
| 17 | NME2 | 2.29574208 |
| 18 | ICK | 2.25311774 |
| 19 | TESK2 | 2.23987879 |
| 20 | NME1 | 2.20707147 |
| 21 | TNIK | 2.11491576 |
| 22 | PRKD3 | 2.04821680 |
| 23 | MAP3K4 | 2.02580447 |
| 24 | MAP3K12 | 2.00569065 |
| 25 | TAOK2 | 1.95091076 |
| 26 | WNK4 | 1.88581983 |
| 27 | DAPK2 | 1.81799468 |
| 28 | GRK5 | 1.76691356 |
| 29 | MARK1 | 1.74647123 |
| 30 | PNCK | 1.68441842 |
| 31 | BCR | 1.66431853 |
| 32 | CAMK2D | 1.66348121 |
| 33 | CDK19 | 1.65835905 |
| 34 | MAP2K7 | 1.65261387 |
| 35 | EPHA2 | 1.65147741 |
| 36 | MINK1 | 1.63750915 |
| 37 | CAMK2B | 1.63138903 |
| 38 | MAP3K9 | 1.61677577 |
| 39 | TAOK1 | 1.59228984 |
| 40 | EPHB2 | 1.55276847 |
| 41 | OBSCN | 1.48781962 |
| 42 | DDR2 | 1.44946412 |
| 43 | MAP2K4 | 1.44146019 |
| 44 | CAMK2G | 1.42716133 |
| 45 | GRK7 | 1.38886780 |
| 46 | PAK4 | 1.35600767 |
| 47 | FGFR4 | 1.33619106 |
| 48 | CAMK2A | 1.32687875 |
| 49 | PIM2 | 1.32361707 |
| 50 | NTRK1 | 1.32249672 |
| 51 | PKN1 | 1.27697663 |
| 52 | PRKG2 | 1.20962044 |
| 53 | PAK3 | 1.20826188 |
| 54 | PTK6 | 1.20766278 |
| 55 | CAMKK2 | 1.18950287 |
| 56 | PRPF4B | 1.17537560 |
| 57 | PAK6 | 1.17478905 |
| 58 | PLK2 | 1.16921204 |
| 59 | LMTK2 | 1.16710665 |
| 60 | NTRK2 | 1.16294250 |
| 61 | PDGFRA | 1.14768751 |
| 62 | MAPK15 | 1.13428910 |
| 63 | MARK2 | 1.12608497 |
| 64 | AKT3 | 1.12100483 |
| 65 | PTK2 | 1.10965634 |
| 66 | MAPKAPK5 | 1.09516885 |
| 67 | CDK5 | 1.08823505 |
| 68 | PINK1 | 1.07371796 |
| 69 | MYLK | 1.07109210 |
| 70 | EPHB1 | 1.06816599 |
| 71 | PRKCG | 1.05681511 |
| 72 | MAP3K10 | 1.04967695 |
| 73 | BRAF | 1.04948795 |
| 74 | MAP3K2 | 1.04714227 |
| 75 | ROCK2 | 1.01957262 |
| 76 | MAP3K1 | 1.01524317 |
| 77 | PKN2 | 0.99966276 |
| 78 | CDC42BPA | 0.99716552 |
| 79 | EEF2K | 0.99369389 |
| 80 | RPS6KA2 | 0.98289202 |
| 81 | PRKD2 | 0.97646320 |
| 82 | PRKCE | 0.96679606 |
| 83 | UHMK1 | 0.94749041 |
| 84 | ABL2 | 0.93918734 |
| 85 | KDR | 0.93751429 |
| 86 | BMPR2 | 0.92406094 |
| 87 | BMX | 0.89514774 |
| 88 | SGK223 | 0.89261211 |
| 89 | SGK494 | 0.89261211 |
| 90 | WNK1 | 0.86790701 |
| 91 | SIK2 | 0.86583210 |
| 92 | MAP4K1 | 0.86151902 |
| 93 | MST4 | 0.84561079 |
| 94 | KSR2 | 0.84543961 |
| 95 | MUSK | 0.84527841 |
| 96 | MAPK13 | 0.83261288 |
| 97 | PDK4 | 0.83062564 |
| 98 | PDK3 | 0.83062564 |
| 99 | FER | 0.82749412 |
| 100 | MAP3K3 | 0.81034321 |
| 101 | DYRK1B | 0.80708236 |
| 102 | MATK | 0.79197395 |
| 103 | WNK3 | 0.78364777 |
| 104 | TBK1 | 0.77608521 |
| 105 | LIMK1 | 0.75693129 |
| 106 | BCKDK | 0.75044756 |
| 107 | IRAK2 | 0.74329599 |
| 108 | LATS2 | 0.71606670 |
| 109 | FGR | 0.70872904 |
| 110 | MAP2K3 | 0.68561761 |
| 111 | CDK14 | 0.66724353 |
| 112 | TTN | 0.62726317 |
| 113 | DMPK | 0.61554420 |
| 114 | PRKACA | 0.61534183 |
| 115 | SCYL2 | 0.61080983 |
| 116 | CSNK1G3 | 0.60814207 |
| 117 | CAMK1 | 0.59605039 |
| 118 | MAP3K8 | 0.58976926 |
| 119 | SIK3 | 0.58866207 |
| 120 | DAPK1 | 0.58577267 |
| 121 | CDK18 | 0.56561900 |
| 122 | CDK12 | 0.55676906 |
| 123 | CDK15 | 0.54822236 |
| 124 | CSNK1G2 | 0.53585412 |
| 125 | STK11 | 0.52954838 |
| 126 | RIPK4 | 0.52424060 |
| 127 | PDPK1 | 0.52252295 |
| 128 | ADRBK2 | 0.51199124 |
| 129 | MAP3K13 | 0.50148823 |
| 130 | DAPK3 | 0.49986557 |
| 131 | IRAK1 | 0.49832659 |
| 132 | PDK2 | 0.49505883 |
| 133 | FES | 0.48711577 |
| 134 | RPS6KL1 | 0.48105829 |
| 135 | RPS6KC1 | 0.48105829 |
| 136 | MTOR | 0.47411807 |
| 137 | MST1R | 0.46821050 |
| 138 | MAP2K1 | 0.46088802 |
| 139 | PTK2B | 0.45950066 |
| 140 | ADRBK1 | 0.45944966 |
| 141 | CDK11A | 0.45315867 |
| 142 | MOS | 0.44548795 |
| 143 | ZAP70 | 0.44235565 |
| 144 | MAP2K2 | 0.43893293 |
| 145 | MET | 0.43683478 |
| 146 | MAPK12 | 0.42432260 |
| 147 | FGFR2 | 0.42038737 |
| 148 | KSR1 | 0.41674042 |
| 149 | NEK6 | 0.41205494 |
| 150 | TYRO3 | 0.40808785 |
| 151 | CAMK1D | 0.40224897 |
| 152 | CAMKK1 | 0.39837647 |
| 153 | LRRK2 | 0.39486454 |
| 154 | HIPK2 | 0.38088585 |
| 155 | PRKCA | 0.36969005 |
| 156 | CSNK1A1L | 0.36689256 |
| 157 | PRKG1 | 0.36627191 |
| 158 | MAPKAPK3 | 0.36156687 |
| 159 | SRC | 0.35750943 |
| 160 | GRK6 | 0.35413240 |
| 161 | CSK | 0.33549586 |
| 162 | FYN | 0.33512899 |
| 163 | MAP3K6 | 0.32559416 |
| 164 | MAP3K14 | 0.32024442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.21621277 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.66807895 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.39187505 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.08167513 |
| 5 | Alzheimers disease_Homo sapiens_hsa05010 | 2.84316429 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.83951611 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.48864722 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.48009389 |
| 9 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.47135249 |
| 10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.36932997 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 2.28102200 |
| 12 | Nicotine addiction_Homo sapiens_hsa05033 | 2.21251626 |
| 13 | Huntingtons disease_Homo sapiens_hsa05016 | 2.14815870 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.07142659 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.03388624 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.01327421 |
| 17 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.92604027 |
| 18 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.89864651 |
| 19 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.86387613 |
| 20 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.86214513 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.84526748 |
| 22 | GABAergic synapse_Homo sapiens_hsa04727 | 1.81954495 |
| 23 | Galactose metabolism_Homo sapiens_hsa00052 | 1.75875538 |
| 24 | Prion diseases_Homo sapiens_hsa05020 | 1.75323751 |
| 25 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.71556106 |
| 26 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.70379118 |
| 27 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.63698067 |
| 28 | Morphine addiction_Homo sapiens_hsa05032 | 1.56405376 |
| 29 | Sulfur relay system_Homo sapiens_hsa04122 | 1.55699239 |
| 30 | Circadian entrainment_Homo sapiens_hsa04713 | 1.50350019 |
| 31 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.47803018 |
| 32 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.47375992 |
| 33 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.47339907 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.40725144 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.40197160 |
| 36 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.39913463 |
| 37 | Taste transduction_Homo sapiens_hsa04742 | 1.38468882 |
| 38 | Bladder cancer_Homo sapiens_hsa05219 | 1.37099004 |
| 39 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.36922978 |
| 40 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.36070589 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35244578 |
| 42 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.33921024 |
| 43 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.30777943 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.26686683 |
| 45 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.24133802 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24114831 |
| 47 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.23986777 |
| 48 | Salivary secretion_Homo sapiens_hsa04970 | 1.23758730 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.21895086 |
| 50 | Insulin secretion_Homo sapiens_hsa04911 | 1.20852648 |
| 51 | Endocytosis_Homo sapiens_hsa04144 | 1.20438955 |
| 52 | Long-term potentiation_Homo sapiens_hsa04720 | 1.17892049 |
| 53 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.16560889 |
| 54 | Renin secretion_Homo sapiens_hsa04924 | 1.14378752 |
| 55 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.11971483 |
| 56 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.11498338 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.10795995 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 1.09706646 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.08954158 |
| 60 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.08463475 |
| 61 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.08213394 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.06959516 |
| 63 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.06586849 |
| 64 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.04816627 |
| 65 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04566875 |
| 66 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.01462023 |
| 67 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.97672391 |
| 68 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.97341788 |
| 69 | Phototransduction_Homo sapiens_hsa04744 | 0.95700690 |
| 70 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.94567095 |
| 71 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.93389179 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.93185180 |
| 73 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.92838403 |
| 74 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91763621 |
| 75 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.90703801 |
| 76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.90650108 |
| 77 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.90014914 |
| 78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88489060 |
| 79 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87860588 |
| 80 | Long-term depression_Homo sapiens_hsa04730 | 0.86532647 |
| 81 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.85518699 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.85377286 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85048640 |
| 84 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.83907942 |
| 85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.81793912 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.81785769 |
| 87 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.80398395 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80243257 |
| 89 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.79496245 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78752730 |
| 91 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78649971 |
| 92 | Histidine metabolism_Homo sapiens_hsa00340 | 0.77935563 |
| 93 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.77433743 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | 0.76256911 |
| 95 | Axon guidance_Homo sapiens_hsa04360 | 0.75679318 |
| 96 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.74255484 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.73355898 |
| 98 | Cocaine addiction_Homo sapiens_hsa05030 | 0.72867221 |
| 99 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71322312 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.70825541 |
| 101 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70623954 |
| 102 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70349249 |
| 103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70161196 |
| 104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.70117451 |
| 105 | Tuberculosis_Homo sapiens_hsa05152 | 0.69418004 |
| 106 | Proteasome_Homo sapiens_hsa03050 | 0.69151370 |
| 107 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.69088339 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.68782644 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.68516972 |
| 110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.68111287 |
| 111 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.66624541 |
| 112 | Amoebiasis_Homo sapiens_hsa05146 | 0.66481611 |
| 113 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66131263 |
| 114 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.65286160 |
| 115 | Apoptosis_Homo sapiens_hsa04210 | 0.64179098 |
| 116 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.63995519 |
| 117 | Pertussis_Homo sapiens_hsa05133 | 0.63900613 |
| 118 | Protein export_Homo sapiens_hsa03060 | 0.63873582 |
| 119 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.61282641 |
| 120 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61076102 |
| 121 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60699420 |
| 122 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60571262 |
| 123 | Carbon metabolism_Homo sapiens_hsa01200 | 0.60496586 |
| 124 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.60450538 |
| 125 | Peroxisome_Homo sapiens_hsa04146 | 0.59870285 |
| 126 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.59251449 |
| 127 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58568447 |
| 128 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.58384935 |
| 129 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56865800 |
| 130 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56641141 |
| 131 | Gap junction_Homo sapiens_hsa04540 | 0.56577584 |
| 132 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56507695 |
| 133 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54551184 |
| 134 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.54162225 |
| 135 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.53553187 |
| 136 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.53320097 |
| 137 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53216168 |
| 138 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52741672 |
| 139 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.52307526 |
| 140 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.51813642 |
| 141 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50274232 |
| 142 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48359348 |
| 143 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.47876405 |
| 144 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47751463 |
| 145 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.47152885 |
| 146 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.47034556 |
| 147 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.47034314 |
| 148 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.46992287 |
| 149 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46722005 |
| 150 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.45861187 |
| 151 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45460353 |
| 152 | Melanogenesis_Homo sapiens_hsa04916 | 0.44955492 |
| 153 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44832831 |
| 154 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.44009188 |
| 155 | Leishmaniasis_Homo sapiens_hsa05140 | 0.43815005 |
| 156 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.43357385 |
| 157 | Adherens junction_Homo sapiens_hsa04520 | 0.42614067 |
| 158 | Focal adhesion_Homo sapiens_hsa04510 | 0.42532080 |
| 159 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41667639 |
| 160 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41594444 |
| 161 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41263045 |
| 162 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.39573816 |
| 163 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37021905 |
| 164 | Phagosome_Homo sapiens_hsa04145 | 0.36522514 |
| 165 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.35399717 |
| 166 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.35142058 |
| 167 | Bile secretion_Homo sapiens_hsa04976 | 0.34506845 |
| 168 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.30285657 |
| 169 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.30048385 |
| 170 | Tight junction_Homo sapiens_hsa04530 | 0.29943204 |
| 171 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28917033 |

